Solely to remove it from the existing pharmaceutical company paradigm where manufacturing is probably not prioritised relative to drug development / marketing / sales. Hard to find capital for expansion of facilities if it being used up buying large, expensive, unprofitable drug portfolios...
Solely to remove it from the existing pharmaceutical company...
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.27 |
Change
-0.100(1.36%) |
Mkt cap ! $618.4M | |||
| Open | High | Low | Value | Volume |
| $7.38 | $7.40 | $7.22 | $619.2K | 85.10K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5080 | $7.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.30 | 389 | 1 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$7.27 |
Change
-0.100 ( 0.69 %) |
||||
| Open | High | Low | Volume | ||
| $7.40 | $7.40 | $7.22 | 17278 | ||
| Last updated 15.59pm 06/05/2024 ? | |||||
| MYX (ASX) Chart |